BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 8235982)

  • 1. Comparison of early glottic and supraglottic carcinoma treated with conventional fractionation of radiotherapy.
    Inoue T; Inoue T; Ikeda H; Teshima T; Yamazaki H; Murayama S; Othani M; Ozeki S
    Strahlenther Onkol; 1993 Oct; 169(10):584-9. PubMed ID: 8235982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical assessment of tumor clearance during radiotherapy as a prognostic factor of early glottic carcinoma.
    Inoue T; Inoue T; Ikeda H; Teshima T; Murayama S
    Strahlenther Onkol; 1992 Oct; 168(10):579-83. PubMed ID: 1440229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overall time in telecobalt therapy for T1 glottic carcinoma treated with 2 Gy per day.
    Inoue T; Inoue T; Teshima T; Murayama S; Yamazaki H; Nose T; Tanaka E
    Strahlenther Onkol; 1995 Aug; 171(8):475-7. PubMed ID: 7652672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperfractionated accelerated radiotherapy for T1,2 glottic carcinoma. Consideration of time-dose factors.
    Sakata K; Someya M; Hori M; Nakata K; Takagi M; Hareyama M
    Strahlenther Onkol; 2008 Jul; 184(7):364-9. PubMed ID: 19016035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation therapy for larynx carcinoma: long-term results of stage I glottic carcinoma.
    Chatani M; Matayoshi Y; Masaki N
    Strahlenther Onkol; 1993 Feb; 169(2):102-6. PubMed ID: 8451724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients.
    Franchin G; Minatel E; Gobitti C; Talamini R; Vaccher E; Sartor G; Politi D; Trovò MG; Barzan L
    Cancer; 2003 Aug; 98(4):765-72. PubMed ID: 12910521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late local recurrence after radiotherapy for tongue and early glottic carcinoma.
    Inoue T; Inoue T; Teshima T; Murayama S; Nose T; Tanaka E; Yamazaki H; Koizumi M; Kagawa K; Ozeki S; Ikeda H
    Strahlenther Onkol; 1996 Jun; 172(6):301-5. PubMed ID: 8677501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial laryngectomy after irradiation failure.
    Yiotakis J; Stavroulaki P; Nikolopoulos T; Manolopoulos L; Kandiloros D; Ferekidis E; Adamopoulos G
    Otolaryngol Head Neck Surg; 2003 Feb; 128(2):200-9. PubMed ID: 12601315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation therapy for early glottic carcinoma (T1N0M0). The final results of prospective randomized study concerning radiation field.
    Chatani M; Matayoski Y; Masaki N; Teshima T; Inoue To
    Strahlenther Onkol; 1996 Mar; 172(3):169-72. PubMed ID: 8721266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors in telecobalt therapy for early supraglottic carcinoma.
    Inoue T; Matayoshi Y; Inoue T; Ikeda H; Teshima T; Murayama S
    Cancer; 1993 Jul; 72(1):57-61. PubMed ID: 8508430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conservative treatment of early glottic carcinomas with exclusive radiotherapy.
    Thariat J; Bruchon Y; Bonnetain F; Barillot I; Truc G; Peignaux K; Horiot JC; Maingon P
    Cancer Radiother; 2004 Oct; 8(5):288-96. PubMed ID: 15561594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of pretreatment hemoglobin level in patients with T1 glottic cancer.
    Canaday DJ; Regine WF; Mohiuddin M; Zollinger W; Machtay M; Lee J; Schultz D; Rudoltz MS
    Radiat Oncol Investig; 1999; 7(1):42-8. PubMed ID: 10030623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotherapy of laryngeal cancer. General principles and results in T1 and T2 cases.
    De Schryver A
    Acta Otorhinolaryngol Belg; 1992; 46(2):187-95. PubMed ID: 1605021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of radiotherapy in early glottic carcinoma.
    Smee RI; Meagher NS; Williams JR; Broadley K; Bridger GP
    Head Neck; 2010 Jul; 32(7):850-9. PubMed ID: 20029987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of treatment for laryngeal carcinoma in Würzburg].
    Bohndorf W; Höcker G
    Strahlentherapie; 1976 Feb; 151(2):132-43. PubMed ID: 1258083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of accelerated fractionated irradiation for supraglottic carcinoma: assessment of results.
    Wang CC; Nakfoor BM; Spiro IJ; Martins P
    Cancer J Sci Am; 1997; 3(2):88-91. PubMed ID: 9099458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical results of conventional fractionation radiotherapy for glottic and supraglottic laryngeal cancers--the usefulness of hyperfractionation for these cancers].
    Masunaga S; Ono K; Tsutsui K; Abe M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Feb; 50(2):139-45. PubMed ID: 2362794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative estimation of cure rates for supraglottic and glottic cancer in radiotherapy.
    Goleń M; Składowski K; Maciejewski B
    Neoplasma; 1999; 46(1):66-71. PubMed ID: 10355537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy with 6-megavolt photons for early glottic carcinoma: potential impact of extension to the posterior vocal cord.
    Lee JH; Machtay M; McKenna MG; Weinstein GS; Markiewicz DA; Krisch RE; Kligerman MM
    Am J Otolaryngol; 2001; 22(1):43-54. PubMed ID: 11172214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factor of telecobalt therapy for early glottic carcinoma.
    Inoue T; Inoue T; Ikeda H; Teshima T; Murayama S
    Cancer; 1992 Dec; 70(12):2797-801. PubMed ID: 1451057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.